LYTIR

Insider · SEC Form 4 · Executive Chairman

Craig Adam R

In the 12 months to Nov 8, 2026, on the open market: bought $12K of XFOR; sold $211K of XFOR. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $12K in total; Insider sales: $211K in total.Aug: Insider sales $211KOct: Insider purchases $12KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $12KInsider sales below: $211K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. XFORBought: X4 Pharmaceuticals, Inc Oct 16, 2026 4,600 shares filed Oct 19, 2026 333,251 shares held directly after, as filed filing $12K
  2. XFORSold: X4 Pharmaceuticals, Inc Aug 12, 2026 47,436 shares filed Aug 13, 2026 328,651 shares held directly after, as filed filing $211K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.